Teva Pharma to Cut 14,000 Jobs as Generic-Drug Business Suffers

Teva Pharmaceutical is cutting more than 25% of its workforce and suspending its dividend as it works to cut costs and pay down debt.

from WSJ.com: US Business http://ift.tt/2C82aoK
via IFTTT